Kentucky Mulls Cutback On Medicaid Cancer Drugs
Health officials in Kentucky are considering a move to restrict cancer medications that Medicaid patients can receive without prior approval.
The move comes as officials look to cut costs in the program that pays for medical care for more than 800,000 elderly, poor and disabled Kentuckians.
It has raised questions from some, including James Sharp of the American Cancer Society. Sharp told the Lexington Herald-Leader that the organization doesn’t want “anything that would remotely restrict access to care.”
A committee of health care providers has recommended that Cabinet for Health and Family Services Secretary Janie Miller put three drugs on Medicaid’s non-preferred list. The drugs are relatively new and can be expensive.
A decision is expected in the next month.